The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor

BACKGROUND: An increasing number of patients are treated with direct-acting oral anticoagulants (DOACs), but the optimal way to reverse the anticoagulant effect is not known. Specific antidotes are not available and prothrombin complex concentrate (PCC), activated PCC (aPCC) and recombinant factor V...

Descripción completa

Detalles Bibliográficos
Autores principales: Schultz, Nina Haagenrud, Tran, Hoa Thi Tuyet, Bjørnsen, Stine, Henriksson, Carola Elisabeth, Sandset, Per Morten, Holme, Pål Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319105/
https://www.ncbi.nlm.nih.gov/pubmed/28239301
http://dx.doi.org/10.1186/s12959-017-0129-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319105/
https://www.ncbi.nlm.nih.gov/pubmed/28239301
http://dx.doi.org/10.1186/s12959-017-0129-1

Ejemplares similares